Literature DB >> 15118246

Donor and recipient rat strains affect full-term development of one-cell zygotes cultured to morulae/blastocysts.

Megumi Kato1, Ayako Ishikawa, Shinichi Hochi, Masumi Hirabayashi.   

Abstract

The present study was conducted to examine the developmental potential to offspring of rat embryos cultured from 1-cell to morula/blastocyst stage. Pronuclear zygotes from Wistar x Wistar or (SD x DA) x Wistar strains were cultured in modified rat 1-cell embryo culture medium (mR1ECM) for 96 h in 5% CO(2) in air at 37 C. The proportion of the 3-way cross hybrid zygotes developing into morula/blastocyst stage (74%) was higher than that of the Wistar zygotes (66%). Day-5 morulae/blastocysts developed in vitro were transferred into Day-3 or -4 pseudopregnant recipients of Wistar or SD x DA strain. The transfer of cultured embryos resulted in the birth of offspring at 13-59%, while that of non-cultured control blastocysts showed birth rates of 35-65%. The best offspring rate of cultured embryos (59%) was obtained when the hybrid 1-cell zygotes were cultured in mR1ECM medium and transferred into the 2-days earlier uteri of SD x DA recipients. These results suggest that genetic background of recipients as well as donors is a possible factor affecting full-term development of rat morulae/blastocysts derived from 1-cell stage zygotes cultured in vitro.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118246     DOI: 10.1262/jrd.50.191

Source DB:  PubMed          Journal:  J Reprod Dev        ISSN: 0916-8818            Impact factor:   2.214


  2 in total

1.  Strain differences in superovulatory response, embryo development and efficiency of transgenic rat production.

Authors:  Elena Popova; Michael Bader; Alexander Krivokharchenko
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

2.  Generation of Hprt-disrupted rat through mouse←rat ES chimeras.

Authors:  Ayako Isotani; Kazuo Yamagata; Masaru Okabe; Masahito Ikawa
Journal:  Sci Rep       Date:  2016-04-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.